Botanical species · safety record

Stephania tetrandra

The EFSA Compendium of Botanicals holds 3 constituent measurements for Stephania tetrandra. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Stephania tetrandra S.Moore

3Constituent measurements

0Safety records

2Cited sources

120Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 120 licensed products naming Stephania tetrandra as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Radix
Root
Whole plant(s)

What the records describe

Constituents measured

Plant parts

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Aristolochia	Fruit unspecified	—	20.3 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Bisbenzylisoquinoline alkaloids	Unspecified	—	≤ 1.3 Percent	Unspecified	No resolvable identifier
Bisbenzylisoquinoline alkaloids	Unspecified	—	≥ 0.7 Percent	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

VANHERWEGHEM, JL., DEPIERREUX, M., TIELEMANS, C., ABRAMOWICZ, D., DRATWA, M., JADOUL, M., RICHARD, C., VANDERVELDE, D., VERBEELEN, D., VANHAELENFASTRE, R., VANHAELEN, M. RAPIDLY PROGRESSIVE INTERSTITIAL RENAL FIBROSIS IN YOUNG-WOMEN - ASSOCIATION WITH SLIMMING REGIMEN INCLUDING CHINESE HERBS . Lancet, 1993, vol. 341, no. 8842, p. 387-391.
Chan, W., Hui, K.M., Poon, W.T., Lee, K.C., Cai, Z. Differentiation of herbs linked to Chinese herb nephropathy from the liquid chromatographic determination of aristolochic acids. Analytica chimica acta, 2006, vol. 576, no. 1, p. 112-116. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature